相关实验视频

Updated: Jun 26, 2025

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

长期的E.E.可能会发生. 用一系列调制的极低频电磁场治疗的抗药性囊炎:对148例病例的随机研究

Ivan D'Agostino¹, F Marelli²

¹Independent Researcher, ID Medicals, 00163 Rome, Italy.

Journal of clinical medicine

|May 11, 2024

概括

测序电磁场有效治疗由耐药大肠杆菌 (E. coli) 引起的慢性细菌囊炎. 这种低频率,低强度的治疗显示出感染标志物和症状的显著减少,没有副作用.

科学领域:

生物物理学的生物物理.
传染性疾病传染性疾病
医疗技术医疗技术医学技术

背景情况:

由耐药大肠杆菌 (E. coli) 引起的慢性细菌性囊炎是一个重大治疗挑战.
研究新的治疗方式对于管理耐药性感染至关重要.

研究的目的:

评估序列电磁场 (EMF) 在治疗耐药大肠杆菌诱导的慢性细菌囊炎的疗效.
评估EMF对关键实验室参数和症状表现的影响.

主要方法:

一项随机对照试验,涉及148名患有耐药大肠杆菌诱导的慢性细菌囊炎的女性参与者.
参与者被分配到EMF治疗 (实验组) 或安慰剂 (对照组).
评估包括症状表现和实验室参数 (D-DIMER,IL-6,红细胞,白细胞,大肠杆菌水平) 在基线,4周和12周.

主要成果:

在EMF组与对照组 (p < 0.001) 相比,在第4周观察到D-DIMER,IL-6,红细胞,白细胞和大肠杆菌水平的显著降低,并持续到第12周.
电磁场治疗显示出对耐药大肠杆菌有强大的抗菌作用.
在实验组中没有报告任何不良副作用.

结论:

测序电磁场为耐药大肠杆菌引起的慢性细菌囊炎提供了有希望的,有效的替代治疗方法.
该疗法表现出显著的抗菌性质和症状缓解.
这种方法需要进一步研究,以便在治疗耐药性尿路感染方面进行临床应用.

关键词:

BSBI (信号序列) 是指一个信号序列.大肠杆菌 (大肠杆菌) (Escherichia coli) 是一个极低频率 (ELF) 是指极低频率的频率.电磁场 (EMF) (电磁场) 是一个电磁场.脉冲电磁场 (PEMF) 是指脉冲的电磁场.骨科医生评估骨质病的评估骨科医学的地标标.骨质病患者的触摸.

更多相关视频

Transurethral Instillation Procedure in Adult Male Mouse

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging

Published on: June 14, 2021

相关概念视频

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...